Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Schepisi

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Future Oncology (London, England)|March 19, 2019
Reclassification of good-risk seminoma: prognostic factors, novel biomarkers and implications for clinical managementChiara Casadei, Giuseppe Schepisi, Cecilia Menna, et al.
Frontiers in Endocrinology|March 13, 2019
Psychosocial Issues in Long-Term Survivors of Testicular CancerGiuseppe Schepisi, Silvia De Padova, Delia De Lisi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 22, 2020
Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancerGiuseppe L Banna, Valeria Urzia, Chiara Benanti, et al.
Oncotarget|December 29, 2016
Vitamin D status among long-term survivors of testicular cancerGiuseppe Schepisi, Silvia De Padova, Emanuela Scarpi, et al.
Frontiers in Oncology|September 14, 2020
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose ChemotherapyMaria Concetta Cursano, Barbara Kopf, Emanuela Scarpi, et al.
The Prostate|June 29, 2019
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamideCristian Lolli, Delia De Lisi, Vincenza Conteduca, et al.
Journal of Oncology|October 24, 2019
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological TumorsGiuseppe Schepisi, Nicole Brighi, Maria Concetta Cursano, et al.
Frontiers in Oncology|August 9, 2021
Melphalan as a Promising Treatment for BRCA-Related Ovarian CarcinomaVincenza Conteduca, Emanuela Scarpi, Alberto Farolfi, et al.
Expert Opinion on Pharmacotherapy|August 14, 2020
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancerAmelia Altavilla, Chiara Casadei, Cristian Lolli, et al.
Frontiers in Oncology|February 1, 2021
Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological DistressSilvia De Padova, Milena Urbini, Giuseppe Schepisi, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Future Oncology (London, England)|March 19, 2019
Reclassification of good-risk seminoma: prognostic factors, novel biomarkers and implications for clinical managementChiara Casadei, Giuseppe Schepisi, Cecilia Menna, et al.
Frontiers in Endocrinology|March 13, 2019
Psychosocial Issues in Long-Term Survivors of Testicular CancerGiuseppe Schepisi, Silvia De Padova, Delia De Lisi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 22, 2020
Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancerGiuseppe L Banna, Valeria Urzia, Chiara Benanti, et al.
Oncotarget|December 29, 2016
Vitamin D status among long-term survivors of testicular cancerGiuseppe Schepisi, Silvia De Padova, Emanuela Scarpi, et al.
Frontiers in Oncology|September 14, 2020
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose ChemotherapyMaria Concetta Cursano, Barbara Kopf, Emanuela Scarpi, et al.
The Prostate|June 29, 2019
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamideCristian Lolli, Delia De Lisi, Vincenza Conteduca, et al.
Journal of Oncology|October 24, 2019
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological TumorsGiuseppe Schepisi, Nicole Brighi, Maria Concetta Cursano, et al.
Frontiers in Oncology|August 9, 2021
Melphalan as a Promising Treatment for BRCA-Related Ovarian CarcinomaVincenza Conteduca, Emanuela Scarpi, Alberto Farolfi, et al.
Expert Opinion on Pharmacotherapy|August 14, 2020
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancerAmelia Altavilla, Chiara Casadei, Cristian Lolli, et al.
Frontiers in Oncology|February 1, 2021
Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological DistressSilvia De Padova, Milena Urbini, Giuseppe Schepisi, et al.
Pageof 7